# Aligos Therapeutics, Inc.: Form 8-K, filed Mar 30, 2022

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2022-03-30
- Accepted by EDGAR: Mar 29, 2022, 21:30 ET
- Period: 2022-03-26
- Accession: 0001193125-22-088448
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312522088448/d284014d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312522088448/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312522088448/d284014d8k.htm

Filed Mar 30, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-088448. Last ingested by Listed: Nov 6, 2026, 12:13 ET. No prices; not investment advice.